Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C. (Q42987714)
Jump to navigation
Jump to search
scientific article published on 11 March 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C. |
scientific article published on 11 March 2009 |
Statements
1 reference
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C. (English)
1 reference
Stefan Zeuzem
1 reference
Avidan U Neumann
1 reference
Stephen Pianko
1 reference
Eric M Yoshida
1 reference
Yves Benhamou
1 reference
Moshe Mishan
1 reference
John G McHutchison
1 reference
Erik Pulkstenis
1 reference
G Mani Subramanian
1 reference
11 March 2009
1 reference
1 reference
51
1 reference
1
1 reference
21-28
1 reference
Identifiers
1 reference
1 reference